Docality.com Logo
 
Dr. Phillip  Ng  Md image

Dr. Phillip Ng Md

170 Alameda De Las Pulgas
Redwood City CA 94062
650 278-8888
Medical School: Boston University School Of Medicine - 1994
Accepts Medicare: No
Participates In eRX: Yes
Participates In PQRS: No
Participates In EHR: Yes
License #: A61233
NPI: 1295766178
Taxonomy Codes:
207RN0300X

Request Appointment Information

Awards & Recognitions

About Us

Practice Philosophy

Conditions

Dr. Phillip Ng is associated with these group practices

Procedure Pricing

HCPCS Code Description Average Price Average Price
Allowed By Medicare
HCPCS Code:90960 Description:Esrd srv 4 visits p mo 20+ Average Price:$400.00 Average Price Allowed
By Medicare:
$320.26
HCPCS Code:90961 Description:Esrd srv 2-3 vsts p mo 20+ Average Price:$300.00 Average Price Allowed
By Medicare:
$266.89
HCPCS Code:90966 Description:Esrd home pt serv p mo 20+ Average Price:$273.13 Average Price Allowed
By Medicare:
$265.53
HCPCS Code:90935 Description:Hemodialysis one evaluation Average Price:$85.97 Average Price Allowed
By Medicare:
$81.32
HCPCS Code:99309 Description:Nursing fac care subseq Average Price:$103.81 Average Price Allowed
By Medicare:
$99.35
HCPCS Code:99223 Description:Initial hospital care Average Price:$220.85 Average Price Allowed
By Medicare:
$216.69
HCPCS Code:G0180 Description:MD certification HHA patient Average Price:$67.31 Average Price Allowed
By Medicare:
$63.19
HCPCS Code:99204 Description:Office/outpatient visit new Average Price:$188.59 Average Price Allowed
By Medicare:
$185.54
HCPCS Code:99214 Description:Office/outpatient visit est Average Price:$125.00 Average Price Allowed
By Medicare:
$122.41
HCPCS Code:99233 Description:Subsequent hospital care Average Price:$114.18 Average Price Allowed
By Medicare:
$111.75
HCPCS Code:99308 Description:Nursing fac care subseq Average Price:$77.40 Average Price Allowed
By Medicare:
$75.51
HCPCS Code:99213 Description:Office/outpatient visit est Average Price:$85.00 Average Price Allowed
By Medicare:
$83.12
HCPCS Code:99232 Description:Subsequent hospital care Average Price:$79.74 Average Price Allowed
By Medicare:
$78.06
HCPCS Code:99307 Description:Nursing fac care subseq Average Price:$50.23 Average Price Allowed
By Medicare:
$48.68
HCPCS Code:90945 Description:Dialysis one evaluation Average Price:$96.11 Average Price Allowed
By Medicare:
$94.70
HCPCS Code:90970 Description:Esrd home pt serv p day 20+ Average Price:$10.09 Average Price Allowed
By Medicare:
$8.88
HCPCS Code:90962 Description:Esrd serv 1 visit p mo 20+ Average Price:$205.02 Average Price Allowed
By Medicare:
$203.83
HCPCS Code:99239 Description:Hospital discharge day Average Price:$117.63 Average Price Allowed
By Medicare:
$117.09
HCPCS Code:99310 Description:Nursing fac care subseq Average Price:$147.01 Average Price Allowed
By Medicare:
$146.64
HCPCS Code:99315 Description:Nursing fac discharge day Average Price:$71.63 Average Price Allowed
By Medicare:
$71.63
HCPCS Code:99305 Description:Nursing facility care init Average Price:$141.19 Average Price Allowed
By Medicare:
$141.19
HCPCS Code:99306 Description:Nursing facility care init Average Price:$179.56 Average Price Allowed
By Medicare:
$179.56

HCPCS Code Definitions

90961
End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month
99214
Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A detailed history; A detailed examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 25 minutes are spent face-to-face with the patient and/or family.
99232
Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the patient is responding inadequately to therapy or has developed a minor complication. Typically, 25 minutes are spent at the bedside and on the patient's hospital floor or unit.
90966
End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older
90962
End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month
90945
Dialysis procedure other than hemodialysis (eg, peritoneal dialysis, hemofiltration, or other continuous renal replacement therapies), with single evaluation by a physician or other qualified health care professional
90960
End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month
99204
Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 45 minutes are spent face-to-face with the patient and/or family.
90970
End-stage renal disease (ESRD) related services for dialysis less than a full month of service, per day; for patients 20 years of age and older
99213
Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: An expanded problem focused history; An expanded problem focused examination; Medical decision making of low complexity. Counseling and coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of low to moderate severity. Typically, 15 minutes are spent face-to-face with the patient and/or family.
99223
Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the problem(s) requiring admission are of high severity. Typically, 70 minutes are spent at the bedside and on the patient's hospital floor or unit.
99310
Subsequent nursing facility care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A comprehensive interval history; A comprehensive examination; Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. The patient may be unstable or may have developed a significant new problem requiring immediate physician attention. Typically, 35 minutes are spent at the bedside and on the patient's facility floor or unit.
99309
Subsequent nursing facility care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the patient has developed a significant complication or a significant new problem. Typically, 25 minutes are spent at the bedside and on the patient's facility floor or unit.
99315
Nursing facility discharge day management; 30 minutes or less
99308
Subsequent nursing facility care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of low complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the patient is responding inadequately to therapy or has developed a minor complication. Typically, 15 minutes are spent at the bedside and on the patient's facility floor or unit.
99305
Initial nursing facility care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the problem(s) requiring admission are of moderate severity. Typically, 35 minutes are spent at the bedside and on the patient's facility floor or unit.
99239
Hospital discharge day management; more than 30 minutes
99307
Subsequent nursing facility care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Straightforward medical decision making. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the patient is stable, recovering, or improving. Typically, 10 minutes are spent at the bedside and on the patient's facility floor or unit.
99233
Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the patient is unstable or has developed a significant complication or a significant new problem. Typically, 35 minutes are spent at the bedside and on the patient's hospital floor or unit.
99306
Initial nursing facility care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the problem(s) requiring admission are of high severity. Typically, 45 minutes are spent at the bedside and on the patient's facility floor or unit.
G0180
Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implementation of the plan of care that meets patient's needs, per certification period
90935
Hemodialysis procedure with single evaluation by a physician or other qualified health care professional

Medical Malpractice Cases

None Found

Medical Board Sanctions

None Found

Referrals

NPI
Doctor Name
Specialty
Count
1235225558
Pathology
9,770
1891758892
Internal Medicine
9,434
1992736367
Hematology/Oncology
5,507
1013910777
Pulmonary Disease
5,222
1669486700
Interventional Radiology
3,719
1831192160
Allergy/Immunology
3,499
1407835325
Pulmonary Disease
1,960
1811099435
Ophthalmology
1,874
1205880101
Cardiovascular Disease (Cardiology)
1,570
1568466589
Urology
1,483
*These referrals represent the top 10 that Dr. Ng has made to other doctors

Publications

Effectiveness and Safety of Acute Care Telemedicine for Children with Regular and Special Healthcare Needs. - Telemedicine journal and e-health : the official journal of the American Telemedicine Association
To assess the hypothesis that effectiveness and safety of the Health-e-Access telemedicine model for care of children with special healthcare needs (CSHCN) with acute illness equaled those for care of children in regular childcare and schools (CRS).We examined healthcare use through insurance claims and telemedicine records spanning 5.7 and 7.3 years for CSHCN and CRS, respectively. Effectiveness was measured as telemedicine visit completion, duplication, and adverse events. Completed visits had diagnosis and management decisions made, and treatment implemented, based solely on telemedicine. Duplicating visits addressed related problems in-person following telemedicine visits within 1 or 3 days. An adverse event was defined as an emergency department visit following a telemedicine visit within 3 days for a problem probably related.Comparisons addressing these measures included 483 and 10,008 telemedicine visits by CSHCN and CRS, respectively. Claims files captured health services use for varying periods of time among 300 different CSHCN and among 1,950 different CRS. Among the 483 telemedicine visits initiated for CSHCN over their telemedicine observation period, 9 were not completed. The CSHCN completion rate of 98.1% equaled the 97.6% completion observed among CRS. Within 3 days, in-person visits duplicated 16.1% of telemedicine visits for both CSHCN and CRS. Within 1 day, in-person visits duplicated 5.3% and 8.9% of telemedicine visits for CSHCN and CRS, respectively. Adverse events following telemedicine visits included 0.3% of telemedicine visits for CSHCN and 0.5% for CRS.Observations support safety and effectiveness of Health-e-Access telemedicine for both CSHCN and CRS.
Acute illness care patterns change with use of telemedicine. - Pediatrics
Health-e-Access, a telemedicine service providing care for acute illnesses in children, has delivered >6500 telemedicine visits from 10 primary care practices in Rochester, New York, by using telemedicine access at 22 child care and school sites. The goal was to assess the hypotheses that children served by Health-e-Access received health care more often for acute illnesses but had fewer emergency department (ED) visits and lower health care expenditures than did children without access through this service.By using insurance claims, this case study compared utilization (starting in May 2001) of telemedicine, office, or ED care for children with versus without telemedicine access. Children included in analyses had > or =6 consecutive insurance-covered months through July 2007. Claims data captured all utilization. A total of 19 652 child-months from 1216 children with telemedicine access were matched with respect to age, gender, socioeconomic status, and season with child-months for children without telemedicine availability.The mean age at utilization was 6.71 years, with 79% of all child-months being covered by Medicaid managed care. The overall utilization rate was 305.1 visits per 100 child-years. In multivariate analyses with adjustment for potential confounders, overall illness-related utilization rates (in-person or telemedicine visits per 100 child-years) for all sites were 23.5% greater for children with telemedicine access than for control children, but ED utilization was 22.2% less.The Health-e-Access telemedicine model holds potential to reduce health care costs, mostly through replacement of ED visits for nonemergency problems.
Effect of L-methionine on hot flashes in postmenopausal women: a randomized controlled trial. - Menopause (New York, N.Y.)
Based on a common mechanism of action with gabapentin, we investigated the effects of L-methionine on hot flashes in postmenopausal women.After a 1-week baseline period, 51 postmenopausal women experiencing at least five moderate-severe hot flashes per day were randomized to one of three groups in a 13:13:25 ratio: placebo/placebo, placebo/L-methionine, or L-methionine/L-methionine, respectively (phase 1/phase 2). Phase 1 was 12 weeks long, and phase 2 was 8 weeks long. Participants took 1 g PO BID in phase 1 and 2 g PO BID in phase 2 of either L-methionine or placebo. All participants also took folate 1 mg and methylcobalamin 0.5 mg a day to help minimize the L-methionine-induced elevation in serum homocysteine. The primary outcome variable was the percent change in hot flash composite score from baseline to week 12 obtained from participants' daily hot flash diaries.In phases 1 and 2, there were no significant differences between the L-methionine and placebo groups for any of the hot flash outcome measures. At week 12, there was a mean of 37.4% decrease in hot flash composite score compared with baseline in the L-methionine group and a mean of 33.4% decrease in the placebo group (P = 0.60). There were expected significant increases in fasting serum homocysteine (1.7 and 5.8 micromol/L) and fasting serum methionine (13.9 and 22.3 micromol/L) at weeks 12 and 20, respectively, associated with the two doses of L-methionine therapy relative to placebo therapy.L-methionine therapy seems to be ineffective in the treatment of hot flashes in postmenopausal women.
Optimization of adenoviral vector-mediated transgene expression in the canine brain in vivo, and in canine glioma cells in vitro. - Neuro-oncology
Expression of the immune-stimulatory molecule Fms-like tyrosine kinase 3 ligand (Flt3L) and the conditional cytotoxic enzyme herpes simplex virus type 1 thymidine kinase (HSV1-TK) provides long-term immune-mediated survival of large glioblastoma multiforme (GBM) models in rodents. A limitation for predictive testing of novel antiglioma therapies has been the lack of a glioma model in a large animal. Dogs bearing spontaneous GBM may constitute an attractive large-animal model for GBM, which so far has remained underappreciated. In preparation for a clinical trial in dogs bearing spontaneous GBMs, we tested and optimized adenovirus-mediated transgene expression with negligible toxicity in the dog brain in vivo and in canine J3T glioma cells. Expression of the marker gene beta-galactosidase (beta-Gal) was higher when driven by the murine (m) than the human (h) cytomegalovirus (CMV) promoter in the dog brain in vivo, without enhanced inflammation. In the canine brain, beta-Gal was expressed mostly in astrocytes. beta-Gal activity in J3T cells was also higher with the mCMV than the hCMV promoter driving tetracycline-dependent (TetON) transgene expression within high-capacity adenovirus vectors (HC-Ads). Dog glioma cells were efficiently transduced by HC-Ads expressing mCMV-driven HSV1-TK, which induced 90% reduction in cell viability in the presence of ganciclovir. J3T cells were also effectively transduced with HC-Ads expressing Flt3L under the control of the regulatable TetON promoter system, and as predicted, Flt3L release was stringently inducer dependent. HC-Ads encoding therapeutic transgenes under the control of regulatory sequences driven by the mCMV promoter are excellent vectors for the treatment of spontaneous GBM in dogs, which constitute an ideal preclinical animal model.

Map & Directions

170 Alameda De Las Pulgas Redwood City, CA 94062
View Directions In Google Maps

Nearby Doctors

319 Highland Ter
Woodside, CA 94062
510 207-7281
162 Clinton St
Redwood City, CA 94062
650 692-2529
154 Arch St
Redwood City, CA 94062
650 685-5551
3221 Jefferson Ave Ste 1
Redwood City, CA 94062
732 754-4045
2900 Whipple Ave #130
Redwood City, CA 94062
650 988-8774
170 Alameda De Las Pulgas
Redwood City, CA 94062
650 675-5636
165 Arch St
Redwood City, CA 94062
650 990-0220
2900 Whipple Ave Suite 130
Redwood City, CA 94062
650 988-8774
170 Alameda De Las Pulgas
Redwood City, CA 94062
650 695-5811